trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Targeted therapy for cancer uses drugs or other substances that attack specific cancer cells with less harm to normal cells.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
4 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that targeted therapy for cancer uses drugs or other substances that attack specific cancer cells with less harm to normal cells?

Yes. Targeted cancer therapies employ drugs and other substances engineered to selectively recognize and attack malignant cells while minimizing toxicity and damage to healthy normal tissues.

Verdict: SUPPORTED · 4 sources for, 0 against · Last checked

The analysis

The retrieved literature contains multiple recent reviews detailing how targeted therapy mechanisms (such as antibody-drug conjugates, peptide-drug conjugates, and targeted delivery vehicles) aim to achieve high tumor specificity while sparing normal tissues. The claim is well-supported by these sources.

Evidence for · 4
2026
Get citation
UY, V., HA, M., M, A., J, W., MS, R., & MQ, W. (2026). Superantigens in Cancer Immunotherapy: Mechanisms, Engineering Strategies, and Therapeutic Potential.. doi.org. https://doi.org/10.1096/fj.202602532r

See more details
More for · 3
2026
Get citation
L, Y., M, A., J, M., Y, L., Y, M., L, Q., & Z, H. (2026). Advances of Peptide-Drug Conjugates in the Treatment of Digestive System Tumors.. doi.org. https://doi.org/10.2147/dddt.s635765

2026
Get citation
S, S., A, B., J, R., AK, M., A, K., & B, D. (2026). Understanding the Potential of Antibody-Drug Conjugates Functionalized Engineered Exosomes in Hepatocellular Carcinoma Therapy: A Comprehensive Narrative Review.. doi.org. https://doi.org/10.1002/hsr2.73289

2008
Get citation
Chari, R. V. J. (2008). ChemInform Abstract: Targeted Cancer Therapy: Conferring Specificity to Cytotoxic Drugs. doi.org. https://doi.org/10.1002/chin.200817249

What does the evidence say?

The retrieved literature contains multiple recent reviews detailing how targeted therapy mechanisms (such as antibody-drug conjugates, peptide-drug conjugates, and targeted delivery vehicles) aim to achieve high tumor specificity while sparing normal tissues. The claim is well-supported by these sources.

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work